KALAMAZOO — Pfizer announced today that it will invest $750 million in its Kalamazoo manufacturing facility bringing nearly 300 jobs to the state and Kalamazoo county area.
The project will help ensure uninterrupted supply for medicines and vaccines, including those based on mRNA technology used in its COVID-19 vaccine, according to CEO David Breen.
“Since 2017, Pfizer has invested $5 billion to support the ongoing growth of our manufacturing leadership in the U.S. This expansion is part of our blueprint to grow our U.S. manufacturing base, create more manufacturing jobs, and help ensure patients everywhere can get the medicines they need,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer
Governor Gretchen Whitmer issued a statement praising the investments in Michigan:
“Today, Pfizer is making another bold bet on Michigan’s manufacturing strengths and hardworking people. This $750 million investment will expand capacity at their Kalamazoo facility, creating good-paying jobs and fostering long-term economic opportunity for Michiganders. We brought this investment home thanks to effective collaboration between the state and Pfizer, and I know that Michigan’s future is bright because we have world-leading companies, economic momentum, and the hardest working people on the planet to move us forward.”
Pfizer’s Chief Global Supply Officer and Executive Vice President, Mike McDermott added:
“At Pfizer, we continue to invest in our manufacturing infrastructure, building a more resilient supply chain so patients have the medicines and vaccines they need. The innovations we put into place in response to the pandemic are now part of our everyday ways of working. We are proud to be a leader in U.S. manufacturing and proud of the impact we have on patients and people around the world.”
